2 ms·
This is an insane decision. The drug in question is very niche, so performance data is scant. Deciding on a therapeutic window is a creative judgement call, not
by Daniel_Newby 15y ago
This is an insane decision. The drug in question is very niche, so performance data is scant. Deciding on a therapeutic window is a creative judgement call, not an observation of a fact of nature. Moreover the choice of number of molecules per red blood cell is unconventional and therefore also creative.
- deleted 15y ago[deleted]
- andybak 15y agoDo either of those facts merit patentability? creative != novel and non-obvious. It's a much lower bar. And that is without considering the 'machine and transformation' side of things.